Acknowledgement of Use Sample Clauses

Acknowledgement of Use. You agree to acknowledge the use of any and all MSSNG Data and the
AutoNDA by SimpleDocs
Acknowledgement of Use. 1. Recipient agrees to acknowledge the use of any and all Materials in any and all publications, oral and written presentations, media reports, interviews, and disclosures resulting from any and all analyses of Materials, whether during the term of this Agreement or afterwards. Recipient shall submit a list of all such publications, presentations, media reports, interviews, and disclosures to the NJCTS Sharing Repository Researcher Liaison. The following is the suggested form for acknowledgement in publications: “We acknowledge the receipt of subject samples from the New Jersey Center for Tourette Syndrome Sharing Repository funded by the New Jersey Center for Tourette Syndrome and Associated Disorders and maintained by the Rutgers University Cell and DNA Repository. We thank the subjects for their contribution of blood sample and clinical data. Further description of the samples and the contributing Principal Investigators may be viewed at xxxx://xxx.xxxxx.xxx/TS/ts_index.html.”
Acknowledgement of Use. Licensee agrees to acknowledge use of the Software, in terms of full citation to the Software including name and affiliation of the Author, in any document referencing work using the Software or results obtained by the Software, including but not limited to published research.
Acknowledgement of Use. 1. Recipient shall acknowledge the use of any and all Materials and/or Recruitment Services as part of new research studies, pursuant to the then current acknowledgement guidelines posted on xxxxx.xxx, in any and all publications, oral and written presentations, media reports, interviews, and disclosures resulting from any and all analyses of Materials, whether during the term of this Agreement or afterwards. Recipient shall submit a list of all such publications, presentations, media reports, interviews, and disclosures to the SFARI Research Liaison at least annually, or as requested by Foundation.
Acknowledgement of Use. I understand that the ABF Group may use the Materials on any and all media, including printed matter, promotional materials, e-mail, websites and social media platforms. I understand that the ABF’s use of the Materials may intentionally or unintentionally give rise to the impression that either I or a family member suffers from brain/neurologic disease, and I nevertheless consent to this use. The ABF is not obligated to utilize any of the rights granted in this agreement. I waive the right to inspect or approve any uses of the Materials in connection with this grant, except with respect to the exceptions that I have expressly set forth in the following lines of this agreement, if any:
Acknowledgement of Use. Recipient agrees to acknowledge the use of any and all Materials in any and all publications, oral and written presentations, media reports, interviews, and disclosures resulting from any and all analyses of Materials, whether during the term of this Agreement or afterwards. Recipient shall upload a list of all such publications, presentations, media reports, interviews, and disclosures to the Autism Speaks Grants System. Recipient shall follow the then current guidelines for acknowledging the ATN resource that are posted on xxxxx.xxx. Upon publication of the results of any and all analyses of the Materials, Recipient agrees to forward a supplementary data table that clearly identifies the samples that were selected for analysis and the type of assays performed (i.e., genetic markers, cell culture treatments, etc.). Some of the samples in the ATN resource are shared samples from other researchers. Recipient agrees to acknowledge the use of any and all such shared researcher samples that are identified as such by ATN in any and all publications, oral and written presentations, media reports, interviews, and disclosures resulting from any and all analyses of such samples, whether during the term of this Agreement or afterwards. Recipient agrees to acknowledge the contribution of researchers who generated Researcher Generated Data used by Recipient in any and all publications, written and oral presentations, media reports, interviews, and disclosures resulting from any and all analyses of such Researcher Generated Data, whether during the term of this Agreement or afterwards. As soon as Recipient has a manuscript accepted for publication (whether during the term of this Agreement or afterwards), a copy of the manuscript along with the name of the publication and expected date of publication shall be forwarded to the ATN Clinical Research Program Manager. .
Acknowledgement of Use 
AutoNDA by SimpleDocs

Related to Acknowledgement of Use

  • Acknowledgement 5. Staff and the Respondent agree with the facts set out in Part IV herein for the purposes of this Settlement Agreement only and further agree that this agreement of facts is without prejudice to the Respondent or Staff in any other proceeding of any kind including, but without limiting the generality of the foregoing, any proceedings brought by the MFDA (subject to Part IX) or any civil or other proceedings which may be brought by any other person or agency, whether or not this Settlement Agreement is accepted by the Hearing Panel.

  • Acknowledgement of Support Unless the Province directs the Recipient to do otherwise, the Recipient will, in respect of any Project-related publications, whether written, oral, or visual, acknowledge the Province’s and Canada’s support for the Project.

  • Acknowledgement of Receipt Each of the parties acknowledges receiving an executed copy of this Agreement.

  • ACKNOWLEDGEMENT OF ADDENDA The Bidder shall acknowledge receipt of any addenda issued to this solicitation by completing the blocks below or by completion of the applicable information on the addendum and returning it not later than the date and time for receipt of the bid. Failure to acknowledge an addendum that has a material impact on this solicitation may negatively impact the responsiveness of your bid. Material impacts include but are not limited to changes to specifications, scope of work/services, delivery time, performance period, quantities, bonds, letters of credit, insurance, or qualifications. Addendum No. , Date Addendum No. , Date Addendum No. , Date Addendum No. , Date AUTHORIZED SIGNATORIES/NEGOTIATORS The Bidder represents that the following principals are authorized to sign bids, negotiate and/or sign contracts and related documents to which the bidder will be duly bound. Principal is defined as an employee, officer or other technical or professional in a position capable of substantially influencing the development or outcome of an activity required to perform the covered transaction. Name Title Telephone Number/Email (Signature) (Date) (Title) (Name of Business) The Bidder shall complete and submit the following information with the bid: Type of Organization Sole Proprietorship Partnership Non-Profit Joint Venture* Corporation State of Incorporation: Principal Place of Business (Florida Statute Chapter 607): City/County/State THE PRINCIPAL PLACE OF BUSINESS SHALL BE THE ADDRESS OF THE BIDDER’S PRINCIPAL OFFICE AS IDENTIFIED BY THE FLORIDA DIVISION OF CORPORATIONS. Federal I.D. number is: * Joint venture firms must complete and submit with their Bid Response the form titled “Information for Determining Joint Venture Eligibility”, and a copy of the formal agreement between all joint venture parties. This joint venture agreement must indicate the parties’ respective roles, responsibilities and levels of participation for the project. If proposing as a Joint Venture, the Joint Venture shall obtain and maintain all contractually required insurance in the name of the Joint Venture as required by the Contract. Individual insurance in the name of the parties to the Joint venture will not be accepted. Failure to timely submit the required form along with an attached written copy of the joint venture agreement may result in disqualification of your Bid Response

  • Acknowledgement of Risk (a) The Purchaser acknowledges and understands that its investment in the Securities involves a significant degree of risk, including, without limitation, (i) the Company remains a development stage business with limited operating history and requires substantial funds in addition to the proceeds from the sale of the Securities; (ii) an investment in the Company is speculative, and only Purchasers who can afford the loss of their entire investment should consider investing in the Company and the Securities; (iii) the Purchaser may not be able to liquidate its investment; (iv) transferability of the Securities is extremely limited; (v) in the event of a disposition of the Securities, the Purchaser could sustain the loss of its entire investment; and (vi) the Company has not paid any dividends on its Common Stock since inception and does not anticipate the payment of dividends in the foreseeable future. Such risks are more fully set forth in the SEC Documents;

  • ACKNOWLEDGEMENT OF RISKS 28.1. It shall be noted that due to market conditions and fluctuations, the value of Financial Instruments may increase or decrease, or may even be reduced to zero. Regardless of the information the Company may provide to the Client, the Client agrees and acknowledges the possibility of these cases occurring.

  • Acknowledgement of Understanding I have read this waiver of liability, assumption of risk, and indemnify, fully understand its terms, and understand that I am giving up my rights, including my right to sue. I acknowledge that I am signing the agreement freely and voluntarily, and intend by my signature to a complete and unconditional release of liability, to the greatest extent allowed by law. Printed Name Signature

  • Acknowledgement of Existing Physical Conditions In undertaking the work under this Contract, the Contractor acknowledges that he has visited the premises and has taken into consideration all open and apparent conditions that might affect his work. No claim based on lack of knowledge of existing conditions shall be allowed unless the existing physical conditions cannot be discovered by a reasonably observant person. Any claims relating to conditions that are materially different from the Contract Documents that were not open and apparent may be adjusted as provided in this Part.

  • Acknowledgement and Agreement By execution below, the Transferor expressly acknowledges and consents to the pledge of the 2022-1 SUBI Certificate and the 2022-1 SUBI and the assignment of all rights and obligations of the Transferor related thereto by the Transferee to the Indenture Trustee pursuant to the Indenture for the benefit of the Noteholders. In addition, the Transferor hereby acknowledges and agrees that for so long as the Notes are Outstanding, the Indenture Trustee will have the right to exercise all powers, privileges and claims of the Transferee under this Agreement.

  • Dissemination of Research Findings and Acknowledgement of Controlled-Access Datasets Subject to the NIH GDS Policy It is NIH’s intent to promote the dissemination of research findings from use of controlled-access dataset(s) subject to the NIH GDS Policy as widely as possible through scientific publication or other appropriate public dissemination mechanisms. Approved Users are strongly encouraged to publish their results in peer-reviewed journals and to present research findings at scientific meetings.

Time is Money Join Law Insider Premium to draft better contracts faster.